Ligand validation:5ODR

PE3: 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ODR_PE3_F_503	10%	85%	0.181	0.804	0.47	0.28	-	-	0	0	30%	0.3023
5ODR_PE3_F_502	9%	85%	0.177	0.812	0.47	0.28	-	-	0	0	21%	0.2093
5ODR_PE3_L_502	7%	88%	0.185	0.785	0.5	0.18	-	-	0	0	21%	0.2093
5ODR_PE3_G_701	7%	87%	0.186	0.768	0.5	0.2	-	-	0	0	23%	0.2326
5ODH_PE3_F_502	39%	88%	0.093	0.939	0.46	0.22	-	-	1	0	21%	0.2093
5ODQ_PE3_F_502	18%	79%	0.173	0.901	0.49	0.37	-	-	0	0	21%	0.2093
5ODC_PE3_A_704	16%	89%	0.141	0.842	0.52	0.14	-	-	0	0	26%	0.2558
5ODI_PE3_G_701	2%	81%	0.313	0.743	0.58	0.25	-	-	0	0	33%	0.3256
3TEO_PE3_O_207	100%	75%	0.037	0.99	0.65	0.35	-	-	2	0	93%	0.9302
6JU0_PE3_K_301	49%	98%	0.149	0.928	0.11	0.18	-	-	1	0	81%	0.814
6EN5_PE3_A_726	36%	74%	0.147	0.84	0.55	0.48	-	-	2	0	100%	0.84
4BTL_PE3_A_1546	35%	52%	0.1	0.935	0.45	1.38	-	-	1	0	16%	16.28
4Y5D_PE3_A_201	34%	36%	0.135	0.879	1.15	1.36	2	5	15	0	65%	0.6512

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.